Literature DB >> 10997310

[Morphological changes in melanocytic nevi induced by exogenous factors].

M Tronnier1, M Alexander, M Neitmann, J Brinckmann, H H Wolff.   

Abstract

Malignant melanoma is the most important differential diagnosis in both clinical and histologic examination of melanocytic nevi. UV exposure with an erythemogenic dose and mechanical irritation of melanocytic nevi are able to induce reversible morphologic changes which simulate malignant melanoma. These changes are associated with an increased expression of HMB-45 antigen. In addition, an increased proliferation and repair activity is observed after UV exposure. The increased number of melanocytes located in suprabasal layers of the epidermis is accompanied by a change in keratinocyte adhesion molecule expression. The UV light is also able to influence the adhesive properties of melanocytes in vitro. Therefore, both keratinocyte-derived factors and direct influence of UV on the melanocyte system are probably responsible for the morphologic changes. While these exogenously evoked changes are reversible, the potential biologic relevance--especially a possible role in the initiation of the carcinogenesis cascade--requires clarification.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997310     DOI: 10.1007/s001050051172

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.

Authors:  Szu-Ying Chin; Pei-Ru Wu; Yi-Hsien Shih; Chung-Min Yeh; Woan-Ruoh Lee; Shing-Chuan Shen; Kun-Tu Yeh; Ming-Chung Jiang; Jonathan Te-Peng Tseng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  [DNA copy number changes in the diagnosis of melanocytic tumors].

Authors:  J Bauer; B C Bastian
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.